1 Axéll T, Pindborg JJ, Smith CJ, Van Der Waal I, and an Internacional Collaborative Group on Oral White Lesions. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Upsala. J Oral Pahol Med 1996; 25: 49-54.
2 Pindborg JJ, Reichart PA, Amith CJ. WHO: Histological typing of cancer and precancer of the oral mucosa, 2nd ed. New York: Springer; 1997. p.87.
3 Santana Garay JC. Prevención y diagnóstico del cáncer bucal. 1ra ed. La Habana: Ed Ciencias Médicas; 2002. p. 47-9.
4 Bouquot JE, Whitaker SB. Oral Leukoplakia-rationale for diagnosis and prognosis of its clinical subtypes or “phases”. Quintessence Int 1994; 25: 133-40.
5 Shafer WG, Levy BM. Tumores benignos y malignos de la cavidad bucal. En: Shafer WG, levy BM. Tratado de patología Bucal- 4taed. México: Nueva Editorial Interamericana; 1986. p. 86-217.
6 Hunter T, Pustzal L. Neoplasias. En: Cotran RS, Kumar MD, Path GR, Collins T. Robins: Patología Estructural y Funcional. 6taed. España: Mc Grau-Hill-Interamericana; 2000. p. 277-345.
7 Lence AJ, Fernández GL, Ortiz RM, Chacón RM. Evaluación de la eficacia del programa de control de cáncer bucal en Cuba. Instituto Nacional de Oncología y Radiobiología, Ciudad de la Habana 1997.
8 Bouquot JE. Reviewing oral leukoplakia-clinical concepts for the 1990s. J Amer Dent Assoc1991; 122: 80-2.
9 Bánóczy J and Csiba A. Ocurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study on 120 cases. Oral Surg 1976; 42: 766-9.
10 Rodrigues TL, Costa LJ, Sampaio MC, Costa A. Leucoplasias bucais: relación clínico-histopatológica. Pesqui Odontol Bras 2000; 14: 357-61.
11 Pindborg JJ, Reibel M, Altini M. Subjetivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985; 14: 698-708.
12 Katz HC, Shear M, Altini M. A critical evaluation of epithelial dysplasia in oral mucosal lesions using the Smith-Pindborg method of standardization. J Oral Pathol 1985; 14: 476-82.
13 Carrillo R. Problemas diagnósticos en Displasia oral. Salud Pública Méx 2002; 56: 432-41.
14 Nigro JM, Baker SJ, Prisinger AC, Jessup JM, Hostetter R. Mutations in the p53 Gene occur in diverse human tumour types. Nature 1989; 342: 705-8.
15 Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science 1991; 253: 49-53.
16 Boyle J, Hakim J, Kocch W et al. The incidence of p53 mutations increases with progression oh head and neck cancer. Cancer Res 1993; 53: 4477-80.
17 Lyons SK, Clark AR. Apoptosis and carcinogenesis. Brit Med Bull 1997; 52: 554-69.
18 Oren M, Rotter V. Introduction p53-The first twenty years. Cell Mol Life Sci 1999; 55: 9-11.
19 Lozano G, Elledge SJ. Cancer: p53 sends nucleotides to repair DNA Nature 2000; 404: 24-5.
20 Spinelly OM, Vinai C. Apoptosis: Una forma diferente de morir. Pren Med Arg 1996; 83: 18-27.
21 Shin DM, Kim J, RO JY. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54: 321-6.
22 Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S. P53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 1995; 24: 18-22.
23 Gretchen L. Animal Tissue tecniques. Los Alamos scientific laboratorios. WH Freeman 1962.
24 Kusama K, Okutsu S, Takeda A, Himiya T, Kojima A, Kidokoro Y, Chu L. P53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol med 1998; 24: 11-22.
25 Kikegawa A. Immunohistoquemical analysis of the p53 tumour suppressor gene product in oral leukoplakia. Kokubyo Gakkai Zasshi 2001; 68: 51-9.
26 Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM. Suprabasal p53 immunoexpression is strongly with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 2002; 55: 98-104.
27 Cruz I, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998; 184: 360-8.
28 Shiu MN, Chen TH, Cheng SH, Hehn LJ. Risk factors for leukoplakia and malignant trasnformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000; 82: 1871-4.
29 Rodríguez I, Miranda J, Santana JC. Caracterización y seguimiento de las lesiones precancerosas de la cavidad bucal. Congreso Internacional por el Centenario de la Escuela de Estomatología de la Universidad de la Habana. Ciudad de la Haban; 2000.
30 Bouquot J, Weiland L, Ballard D, Kurland L. Leukoplakia of the mouth and pharynx in Rochester, MN 1935-1984; incidence, clinical features and follow-up of 403 patients from a relatively unbiased patient pool. J Oral Path 1988; 17: 436.
31 Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cel carcinoma Oral Surg Oral Med Oral Pathol 1995; 79: 321-9.
32 Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation a follow-up study of 257 patients. Cancer 1984; 50: 563-8.
33 MINSAP. Programa Nacional de Diagnóstico Precoz del Cáncer Bucal. Ciencias Médicas 1986.
34 Gustav FV. Ultrastructural and Immunopathologic Aspects. Oral cancer and Precancer. 1980.
35 Rosabal López T, Rodríguez Pérez I, Miranda Tarragó J. Índice mitótico en la leucoplasia bucal. Rev Cub Invest Biomed 1987; 6: 421-6.
36 Rodríguez Pérez I, Martínez M, Miranda Tarragó I, Bánóczy J. Keratotic lesions of the oral epithelium. Acta Morphologica Acad Sci Hung 1981; 29: 51-7.
37 Rodríguez Pérez I, Miranda Tarragó J. Ultraestructura del proceso de queratinización en la leucoplasia bucal. Importancia en el diagnóstico. Congreso Internacional por el Centenario de la Fundación de la Escuela de Odontología de la Universidad de La Habana. Ciudad de la Habana 2000.
38 Weinberg RA. How cancer arises. Sci Am 1996; 276: 62-75.
39 Vokes EE, Weichselbaum RR, Lippman SM, HOng WK. Head and neck cancer. N Engl J Med 1993; 328: 184-94.
40 Million RP, Cassisi NJ. Management of head and neck cancer: a multidisciplinary approach. J Oral Oncol 1993; 435: 267-75.
41 Brennan JA, Boyle JO, Koch WM. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-7.
42 Xin Wei Wang. Role of p53 and apoptosis in carcinogenesis. Anticancer Research 1999; 19: 4759-71.
43 Xin W Wang, Curtis C. p53 Tumour suppressor Gene: Clues to Molecular Carcinogenesis. J Cell Physiol 1997; 173: 247-55.